Health Canada
- Status: approved
Rosuvastatin or atorvastatin or simvastatin and clopidogrel (Rosuvastatin or atorvastatin or simvastatin and clopidogrel) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.